RAJESH RETHNAM, MD., FCCP.
Obesity Medicine (Internal Medicine) Physician in HOUSTON, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
RAJESH RETHNAM, MD., FCCP. filed 1,006 Medicare Part D claims in 2023 as a Obesity Medicine (Internal Medicine) Physician in HOUSTON, Texas.
- 1K
- Part D claims, 2023
- $805.34
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
RAJESH RETHNAM, MD., FCCP.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
1,006 Top 24% higher than 76% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
RAJESH RETHNAM, MD., FCCP. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about RAJESH RETHNAM, MD., FCCP.?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Texas
How Obesity Medicine (Internal Medicine) Physician compares to other specialties among Texas providers
Obesity Medicine (Internal Medicine) Physician share within Texas
Obesity Medicine (Internal Medicine) Physician is one of the more visible NUCC categories in Texas
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Obesity Medicine (Internal Medicine) Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Obesity Medicine (Internal Medicine) Physician ABMS/AOA estimate
Est. board-certified rate (Obesity Medicine (Internal Medicine) Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Obesity Medicine (Internal Medicine) Physician US NPIs
Specialty board-certified rate — Obesity Medicine (Internal Medicine) Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
RAJESH RETHNAM, MD., FCCP. appears in the CMS NPPES registry as a Obesity Medicine (Internal Medicine) Physician provider holding MD., FCCP. credentials at 1800 W 26TH ST STE 200, HOUSTON, TX, 77008, with a listed phone of (888) 958-6463. NPI 1275634289 was issued on 09/25/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what RETHNAM most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 1,006 prescription claims written by this provider, covering 158 Medicare beneficiaries and totaling roughly $588K in drug spend. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Obesity Medicine (Internal Medicine) Physician is a narrow specialty nationwide, with 142 enrolled providers across 36 states and an average of 1,046 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1275634289 |
|---|---|
| Specialty | Obesity Medicine (Internal Medicine) Physician |
| Credentials | MD., FCCP. |
| Gender | Male |
| NPI Issued | 09/25/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm RAJESH RETHNAM, MD., FCCP.'s current license status, disciplinary history, and board certifications with the Texas Medical Board in Texas before relying on this page for a clinical or care decision.
How we sourced this profile
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for RAJESH RETHNAM, MD., FCCP.. Source: openpaymentsdata.cms.gov.
Total received
$805
Largest payer
Mylan Specialty L.P.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — Texas TMB 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to RAJESH RETHNAM, MD., FCCP.. To verify RAJESH RETHNAM, MD., FCCP.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,401
- Total Day Supply
- 37,223
- Generic Drug Cost
- $28K
- Antibiotic Claims
- 63
Patient Demographics
- Average Patient Age
- 68.5 years
- Avg HCC Risk Score
- 2.85
- Gender Split
- 53% female / 47% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What RAJESH RETHNAM, MD., FCCP. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Trelegy Ellipta
Trelegy Ellipta
94 claims
- Albuterol Sulfate …
Albuterol Sulfate Hfa
80 claims
- Topiramate
Topiramate
40 claims
- Roflumilast
Roflumilast
39 claims
- Metformin Hcl Er 37
Metformin Hcl Er
37 claims
- Ozempic 33
Ozempic
33 claims
- Prednisone 33
Prednisone
33 claims
- Breo Ellipta 32
Breo Ellipta
32 claims
| Drug | Claims |
|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 94 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 80 |
| Topiramate | 40 |
| Roflumilast | 39 |
| Metformin Hcl Er Metformin Hcl | 37 |
| Ozempic Semaglutide | 33 |
| Prednisone | 33 |
| Breo Ellipta Fluticasone/Vilanterol | 32 |
| Levocetirizine Dihydrochloride | 31 |
| Levalbuterol Hcl | 29 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Obesity Medicine (Internal Medicine) Physician Overview
How RAJESH RETHNAM, MD., FCCP. fits within the Obesity Medicine (Internal Medicine) Physician landscape nationally.
RAJESH RETHNAM, MD., FCCP.'s 1,006 claims are below the specialty average of 1,046.
Nearby Obesity Medicine (Internal Medicine) Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as RETHNAM.
Compare Obesity Medicine (Internal Medicine) Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Texas
Frequently Asked Questions
What is RAJESH RETHNAM, MD., FCCP.'s specialty? ▼
How much does RAJESH RETHNAM, MD., FCCP. prescribe under Medicare Part D? ▼
Where is RAJESH RETHNAM, MD., FCCP. located? ▼
What is RAJESH RETHNAM, MD., FCCP.'s NPI number? ▼
How many Obesity Medicine (Internal Medicine) Physician providers are there in the US? ▼
What drugs does RAJESH RETHNAM, MD., FCCP. prescribe most often? ▼
Does RAJESH RETHNAM, MD., FCCP. accept Medicare? ▼
How can I verify RAJESH RETHNAM, MD., FCCP.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology